This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
UnitedHealth Group, Inc. is the largest health care services company in the world, serving over 50 million individuals in the United States as of 2019 and over 5 million internationally. The company provides a wide range of health care products and services, such as health maintenance organizations (HMOs), point of service plans (POS), preferred provider organizations (PPOs), and managed fee-for-service programs. UnitedHealth has the largest and most diverse membership base within the managed-care organization market, which gives it significant competitive advantages. It also has built its prescription drug business through OptumRx division, with the acquisition of Catamaran in 2015.
Zacks Market Edge Highlights: ExxonMobil, Meta Platforms, UnitedHealth Group, Biogen and NVIDIA
by Zacks Equity Research
ExxonMobil, Meta Platforms, UnitedHealth Group, Biogen and NVIDIA are part of the Zacks Market Edge article.
Should You Sell Your FANGMAN Stocks?
by Tracey Ryniec
Tracey and Kevin discuss the rocky 2022 stock market and the future of growth stocks.
UnitedHealth (UNH) Grows on Optum Strength, Cost Woes Stay
by Zacks Equity Research
UnitedHealth's (UNH) health service business, Optum, is becoming increasingly valuable and is crucial to the company's diversification strategy.
UnitedHealth Group (UNH) Gains But Lags Market: What You Should Know
by Zacks Equity Research
In the latest trading session, UnitedHealth Group (UNH) closed at $523.17, marking a +1.49% move from the previous day.
Why UnitedHealth (UNH) Could Beat Earnings Estimates Again
by Zacks Equity Research
UnitedHealth (UNH) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Cigna's (CI) New Pathwell Suite to Boost Efficiency, Lower Cost
by Zacks Equity Research
Cigna (CI) expects to bump up its Pathwell suite's availability throughout the next year.
Is Vanguard Dividend Appreciation ETF (VIG) a Strong ETF Right Now?
by Zacks Equity Research
Smart Beta ETF report for VIG
How Investors Can Grab Better Returns for Medical Using the Zacks ESP Screener
by Zacks Equity Research
Why investors should use the Zacks Earnings ESP tool to help find stocks that are poised to top quarterly earnings estimates.
Should Vanguard Value ETF (VTV) Be on Your Investing Radar?
by Zacks Equity Research
Style Box ETF report for VTV
UnitedHealth Group (UNH) Gains But Lags Market: What You Should Know
by Zacks Equity Research
UnitedHealth Group (UNH) closed at $513.94 in the latest trading session, marking a +1.1% move from the prior day.
Molina Healthcare (MOH) Wins Medicaid Deal From Nebraska DHHS
by Zacks Equity Research
Molina Healthcare (MOH) clinches a contract from the Nebraska DHHS, through which the health insurer can efficiently serve the state's Medicaid members and boost its statewide presence.
Centene's (CNC) Contract Win to Aid Nebraska's Medicaid Members
by Zacks Equity Research
The Nebraska DHHS awards a contract to Centene's (CNC) Nebraska arm to continue serving the unmet need of the state's Medicaid members with a suite of better healthcare options.
UnitedHealth (UNH) Wins New Medicaid Contract in Nebraska
by Zacks Equity Research
UnitedHealth's (UNH) UnitedHealthcare boasts a network of 100 hospitals and more than 14,000 physicians and caregivers in Nebraska.
The Zacks Analyst Blog Highlights UnitedHealth Group, Johnson & Johnson, Chevron, The Home Depot and AT&T
by Zacks Equity Research
UnitedHealth Group, Johnson & Johnson, Chevron, The Home Depot and AT&T are part of the Zacks top Analyst Blog.
Zacks Industry Outlook Highlights UnitedHealth Group, Humana, Centene and Molina Healthcare
by Zacks Equity Research
UnitedHealth Group, Humana, Centene and Molina Healthcare are part of Zacks Industry Outlook article.
Top Stock Reports for UnitedHealth, Johnson & Johnson, & Chevron
by Sheraz Mian
Today's Research Daily features new research reports on 16 major stocks, including UnitedHealth Group Incorporated (UNH), Johnson & Johnson (JNJ) and Chevron Corporation (CVX).
Dow Jones ETF Avoids Bear Market: 4 Stocks in Green
by Sweta Killa
Both the S&P 500 and the tech-heavy Nasdaq Index are in bear market while the Dow Jones in the only of the three main indexes not to have bear market status.
Why UnitedHealth Group (UNH) is a Top Value Stock for the Long-Term
by Zacks Equity Research
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
New to Investing? This 1 Medical Stock Could Be the Perfect Starting Point
by Zacks Equity Research
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Focus List.
4 HMO Stocks to Watch Despite Escalating Technology Expenses
by Debasmita Chatterjee
A growing customer base and numerous contract wins might drive the Medical-HMO industry. However, high expenses related to technology advancements and a shortage of nurses will dampen margins. Stocks like UNH, HUM, CNC and MOH will likely ride out the industry storms.
3 Medical Stocks Displaying Remarkable Relative Strength in 2022
by Derek Lewis
In addition to favorable price action, all three carry a strong growth profile, making them appear even more enticing.
UnitedHealth Group Incorporated (UNH) is Attracting Investor Attention: Here is What You Should Know
by Zacks Equity Research
Zacks.com users have recently been watching UnitedHealth (UNH) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
Should You Invest in the Fidelity MSCI Health Care Index ETF (FHLC)?
by Zacks Equity Research
Sector ETF report for FHLC
Company News for Sep 21, 2022
by Zacks Equity Research
Companies in The News Are: F,HUM,CHNG,UNH,CGNX
UnitedHealth Group (UNH) Stock Moves -0.14%: What You Should Know
by Zacks Equity Research
UnitedHealth Group (UNH) closed the most recent trading day at $522.80, moving -0.14% from the previous trading session.